Company Data

Gain Therapeutics Inc.

Ticker
GANX
Current Price
$1.77 -1.67%
Market Cap
$52.3M
Price Target
Refer to Report
Volume
157.1K
52wk Range
$0.89 - $3.19
Advanced Market Data

Overview

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy